Work

Outcomes stratified by molecular aberration following induction with daunorubicin 60 mg/m2 versus daunorubicin 90 mg/m2 in AML.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e19035

Authors: Keri Renee Maher, Ian Michael Bouligny

Institution: VCU Massey Comprehensive Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4286298872

Cites:

Cited by:

Related to: 10